Davids E - Search Results

1

Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning.

Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Davids E, et al. Psychopharmacology (Berl). 2002 Feb;160(1):92-8. doi: 10.1007/s00213-001-0962-5. Epub 2001 Dec 18. Psychopharmacology (Berl). 2002. PMID: 11862378

2

Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning.

Zhang K, Tarazi FI, Davids E, Baldessarini RJ. Zhang K, et al. Among authors: davids e. Neuropsychopharmacology. 2002 May;26(5):625-33. doi: 10.1016/S0893-133X(01)00404-3. Neuropsychopharmacology. 2002. PMID: 11927187

3

Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.

Zhang K, Davids E, Tarazi FI, Baldessarini RJ. Zhang K, et al. Among authors: davids e. Psychopharmacology (Berl). 2002 Apr;161(1):100-6. doi: 10.1007/s00213-002-1018-1. Epub 2002 Mar 6. Psychopharmacology (Berl). 2002. PMID: 11967637

4

Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.

Davids E, Zhang K, Kula NS, Tarazi FI, Baldessarini RJ. Davids E, et al. J Pharmacol Exp Ther. 2002 Jun;301(3):1097-102. doi: 10.1124/jpet.301.3.1097. J Pharmacol Exp Ther. 2002. PMID: 12023542

5

Serotonin transporter binding increases in caudate-putamen and nucleus accumbens after neonatal 6-hydroxydopamine lesions in rats: implications for motor hyperactivity.

Zhang K, Davids E, Tarazi FI, Baldessarini RJ. Zhang K, et al. Among authors: davids e. Brain Res Dev Brain Res. 2002 Aug 30;137(2):135-8. doi: 10.1016/s0165-3806(02)00436-4. Brain Res Dev Brain Res. 2002. PMID: 12220705

6

Animal models of attention-deficit hyperactivity disorder.

Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Davids E, et al. Brain Res Brain Res Rev. 2003 Apr;42(1):1-21. doi: 10.1016/s0165-0173(02)00274-6. Brain Res Brain Res Rev. 2003. PMID: 12668288 Review.

7

Organotypic rat cerebellar slice culture as a model to analyze the molecular pharmacology of GABAA receptors.

Davids E, Hevers W, Dämgen K, Zhang K, Tarazi FI, Lüddens H. Davids E, et al. Eur Neuropsychopharmacol. 2002 Jun;12(3):201-8. doi: 10.1016/s0924-977x(02)00024-x. Eur Neuropsychopharmacol. 2002. PMID: 12007671

8

A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder.

Davids E, Kis B, Specka M, Gastpar M. Davids E, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1033-8. doi: 10.1016/j.pnpbp.2006.03.035. Epub 2006 May 15. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16698160 Clinical Trial.

9

Attention deficit hyperactivity disorder and borderline personality disorder.

Davids E, Gastpar M. Davids E, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):865-77. doi: 10.1016/j.pnpbp.2005.04.033. Prog Neuropsychopharmacol Biol Psychiatry. 2005. PMID: 15951086 Review.

10

A rare case of dependence on pemoline.

Bonnet U, Davids E. Bonnet U, et al. Among authors: davids e. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1340-1. doi: 10.1016/j.pnpbp.2006.02.017. Epub 2006 Apr 5. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16600453

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page